137
Participants
Start Date
October 21, 2021
Primary Completion Date
September 4, 2026
Study Completion Date
September 4, 2026
IAG933
Capsule
Novartis Investigative Site, Melbourne
Novartis Investigative Site, Zurich
Novartis Investigative Site, Rozzano
Novartis Investigative Site, Milan
Cleveland Clinic Foundation, Cleveland
Novartis Investigative Site, Essen
Uni of Chi Medi Ctr Hema and Onco, Chicago
University of California LA, Los Angeles
Novartis Investigative Site, Villejuif
Massachusetts General Hospital, Boston
MD Anderson Cancer Center, Houston
Novartis Investigative Site, Montreal
Novartis Investigative Site, Chuo Ku
Novartis Investigative Site, Rotterdam
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Manchester
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY